Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer

BACKGROUND: Aromatase inhibitors (AIs) are more effective than tamoxifen as neoadjuvant endocrine therapy (NET) for hormone receptor (HR)-positive breast cancer. Here we report the surgical and long-term outcome of elderly postmenopausal patients with locally advanced, HR-positive breast cancer trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassadonia, Antonino, Di Nicola, Marta, Grossi, Simona, Noccioli, Paolo, Tavoletta, Saveria, Politi, Roberto, Angelucci, Domenico, Marinelli, Camilla, Zilli, Marinella, Ausili Cefaro, Giampiero, Tinari, Nicola, De Tursi, Michele, Iezzi, Laura, Cioffi, Pasquale, Iacobelli, Stefano, Natoli, Clara, Cianchetti, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975084/
https://www.ncbi.nlm.nih.gov/pubmed/24522992
http://dx.doi.org/10.1245/s10434-014-3535-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975084/
https://www.ncbi.nlm.nih.gov/pubmed/24522992
http://dx.doi.org/10.1245/s10434-014-3535-7

Ejemplares similares